CHE
Price
$511.72
Change
-$3.72 (-0.72%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
6.72B
11 days until earnings call
Intraday BUY SELL Signals
PNTG
Price
$41.92
Change
-$0.35 (-0.83%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
1.43B
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CHE vs PNTG

CHE vs PNTG Comparison Chart in %
View a ticker or compare two or three
VS
CHE vs. PNTG commentary
Oct 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHE is a Hold and PNTG is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CHE with price predictions
Oct 15, 2026

CHE's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for CHE moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 14 of the 22 cases the stock moved higher. This puts the odds of a move higher at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 59 cases where CHE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CHE as a result. In 45 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.

The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 29 of 53 cases over the following month. The odds of a continued upward trend are 55%.

Following a +2.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 162 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.

Bearish Trend Analysis

CHE moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CHE crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

The Aroon Indicator for CHE entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (208.195). P/E Ratio (25.870) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.005) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
a Summary for PNTG with price predictions
Oct 15, 2026

PNTG's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PNTG turned positive on October 12, 2026. Looking at past instances where PNTG's MACD turned positive, the stock continued to rise in 44 of 53 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on PNTG as a result. In 73 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

PNTG moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PNTG crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.

Following a +5.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in 242 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for PNTG moved out of overbought territory on September 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

PNTG broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. PNTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PNTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.978) is normal, around the industry mean (208.195). P/E Ratio (45.011) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.373) is also within normal values, averaging (2.688).

FUNDAMENTALS RATINGS
CHE vs PNTG: Fundamental Ratings
CHE
PNTG
OUTLOOK RATING
1..100
1879
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
8768
SMR RATING
1..100
3672
PRICE GROWTH RATING
1..100
4239
P/E GROWTH RATING
1..100
3014
SEASONALITY SCORE
1..100
8535

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHE's Valuation (12) in the Medical Or Nursing Services industry is significantly better than the same rating for PNTG (84) in the null industry. This means that CHE’s stock grew significantly faster than PNTG’s over the last 12 months.

PNTG's Profit vs Risk Rating (68) in the null industry is in the same range as CHE (87) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.

CHE's SMR Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for PNTG (72) in the null industry. This means that CHE’s stock grew somewhat faster than PNTG’s over the last 12 months.

PNTG's Price Growth Rating (39) in the null industry is in the same range as CHE (42) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.

PNTG's P/E Growth Rating (14) in the null industry is in the same range as CHE (30) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEPNTG
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
49%
Bearish Trend 10 days ago
74%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
33%
N/A
COMPARISON
Comparison
Oct 17, 2026
Stock price -- (CHE: $515.44 vs. PNTG: $42.27)
Brand notoriety: CHE and PNTG are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: CHE: 92% vs. PNTG: 114%
Market capitalization -- CHE: $6.72B vs. PNTG: $1.43B
CHE [@Hospital/Nursing Management] is valued at $6.72B. PNTG’s [@Hospital/Nursing Management] market capitalization is $1.43B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $93.66B. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHE’s FA Score shows that 2 FA rating(s) are green while PNTG’s FA Score has 1 green FA rating(s).

  • CHE’s FA Score: 2 green, 3 red.
  • PNTG’s FA Score: 1 green, 4 red.
According to our system of comparison, CHE is a better buy in the long-term than PNTG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHE’s TA Score shows that 5 TA indicator(s) are bullish while PNTG’s TA Score has 5 bullish TA indicator(s).

  • CHE’s TA Score: 5 bullish, 4 bearish.
  • PNTG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CHE is a better buy in the short-term than PNTG.

Price Growth

CHE (@Hospital/Nursing Management) experienced а +3.45% price change this week, while PNTG (@Hospital/Nursing Management) price change was +4.71% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.81%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +16.84%.

Reported Earning Dates

CHE is expected to report earnings on Oct 27, 2026.

PNTG is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-0.81% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
CHE
Daily Signal:
Gain/Loss:
PNTG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRLS1.080.04
+3.85%
Borealis Foods
BAM45.981.37
+3.07%
Brookfield Asset Management Ltd
BCBP8.310.17
+2.09%
BCB Bancorp
MUR39.850.54
+1.37%
Murphy Oil Corp
LNN110.59-1.49
-1.33%
Lindsay Corp

CHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+0.44%
UHS - CHE
44%
Loosely correlated
+0.79%
PNTG - CHE
33%
Poorly correlated
+3.55%
ENSG - CHE
32%
Poorly correlated
+1.29%
OPCH - CHE
32%
Poorly correlated
+0.32%
NHC - CHE
23%
Poorly correlated
+4.71%
More

PNTG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PNTG has been loosely correlated with UHS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PNTG jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PNTG
1D Price
Change %
PNTG100%
+3.55%
UHS - PNTG
42%
Loosely correlated
+0.79%
CON - PNTG
40%
Loosely correlated
+4.51%
ADUS - PNTG
40%
Loosely correlated
-0.11%
ENSG - PNTG
39%
Loosely correlated
+1.29%
AVAH - PNTG
39%
Loosely correlated
+2.27%
More